Recent News

• 11.13.2025 - Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
• 10.14.2025 - Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025

Recent Filings

• 11.13.2025 - EX-99.1 EX-99.1
• 11.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.13.2025 - 8-K Current report
• 10.17.2025 - 8-K Current report
• 10.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.15.2025 - 4 Statement of changes in beneficial ownership of securities